Sherry Korczynski's most recent trade in Aquestive Therapeutics Inc was a trade of 2,714 Common Stock done . Disclosure was reported to the exchange on June 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jun 2026 | 2,714 | 238,403 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 75,000 | 256,858 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 42,500 | 42,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.17 per share. | 09 Mar 2026 | 15,741 | 241,117 (0%) | 0% | 4.2 | 65,687 | Common Stock |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 25,000 | 181,858 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.54 per share. | 09 Jun 2025 | 2,714 | 156,858 (0%) | 0% | 3.5 | 9,608 | Common Stock |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 90,000 | 165,000 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 67,500 | 67,500 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 35,000 | 35,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 5,428 | 159,572 (0%) | 0% | 2.6 | 14,384 | Common Stock |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | 07 Jun 2024 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock |